In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Johnson & Johnson Q3

This article was originally published in The Rose Sheet

Executive Summary

Worldwide skin care sales advance 15% to $390 mil. in third quarter, led by Neutrogena, Aveeno, Clean & Clear brands, firm says in 1Oct. 15 sales and earnings release. Skin care sales in the U.S. rose 13% to $170 mil. and were up 17% to $169 mil. in international markets. "Continued strength of the overall product line, momentum associated with a broad range of new product offerings launched earlier this year and expanded growth of these equities outside the U.S. were the key drivers" of growth, according to J&J. Baby and kids care sales rose 4% worldwide to $300 mil., reflecting strong sales outside the U.S. of skin care and wipes products. Domestic baby care sales declined 3% to $68 mil., depressed by divestiture of Healthflow and Sippy Cup businesses...



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts